Pharma Journalist -

The U.S. FDA has granted Octapharma with orphan drug designation for Octagam 10%. Octagam 10% is an immune globulin intravenous (human) liquid for the treatment of…
Read More...

Cogstate Ltd announced that Eli Lilly’s has selected Cogstate as preferred provider for Alzheimer’s Disease Platform, to support with solutions to ensure high-quality neuropsychological…
Read More...

Concert Pharmaceuticals received notice from the U.S. FDA that its CTP-543 Phase 2a clinical trial for alopecia areata has been placed on clinical hold. The FDA had previously…
Read More...

CytoDyn In. announced the treatment of the first patient suffering from GvHD(Graft versus Host Disease) with use of PRO 140 during its clinical trial Phase 2. The multicenter,…
Read More...

Dr. Reddy’s Laboratories Ltd. announced that USFDA has approved to launch Doxorubicin Hydrochloride Liposome Injection for intravenous use, in the US market. The approval is an outcome…
Read More...

Dr. Donna Morgan Murray has been appointed as Nativis Chief Regulatory Officer with immediate effective. Murray is author of more than 60 publications in peer-referenced…
Read More...

Saneca Pharma announced that after an inspection Russian Federal State Institution ‘State Institute of Drugs and Good Practices’ has granted them multi-dosage cGMP certificate. cGMP…
Read More...

MilliporeSigma announced that SystImmune has selected its CHOZN Expression System for commercial development of a bi-specific antibody therapeutic. The CHOZN expression system is…
Read More...

AVEO Oncology has appointed Matthew Dallas as CFO (chief financial officer) effective from June 1, 2017. Mr. Dallas will be responsible for the Company’s financial strategy and…
Read More...

Cambrex Corporation will invest $2.4M is to expand pilot plant capacity by around 30% at its High Point, NC facility with the installation of a fourth reactor suite. The new 400 sq.…
Read More...